Citation: Mk. Lacy et al., Comparison of vancomycin pharmacodynamics (1 g every 12 or 24 h) against methicillin-resistant staphylococci, INT J ANT A, 15(1), 2000, pp. 25-30
Citation: Pr. Tessier et al., Postantibiotic effect of trovafloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis in cerebrospinal fluid and broth culture media, DIAG MICR I, 36(4), 2000, pp. 241-247
Authors:
Nicolau, DP
Onyeji, CO
Zhong, MK
Tessier, PR
Banevicius, MA
Nightingale, CH
Citation: Dp. Nicolau et al., Pharmacodynamic assessment of cefprozil against Streptococcus pneumoniae: Implications for breakpoint determinations, ANTIM AG CH, 44(5), 2000, pp. 1291-1295
Citation: Dp. Nicolau et al., Beneficial effect of combination antiplatelet therapy on the development of experimental Staphylococcus aureus endocarditis, INT J ANT A, 11(2), 1999, pp. 159-161
Authors:
Lacy, MK
Lu, W
Xu, XW
Tessier, PR
Nicolau, DP
Quintiliani, R
Nightingale, CH
Citation: Mk. Lacy et al., Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillinagainst Streptococcus pneumoniae in an in vitro model of infection, ANTIM AG CH, 43(3), 1999, pp. 672-677
Authors:
Tessier, PR
Nicolau, DP
Onyeji, CO
Nightingale, CH
Citation: Pr. Tessier et al., Pharmacodynamics of intermittent- and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosain an in vitro infection model, CHEMOTHERA, 45(4), 1999, pp. 284-295